Summary
Substrate-based ablation of ventricular tachycardia (VT) in patients with ischemic cardiomyopathy resulted in fewer VT recurrences and less rehospitalization compared with the conventional clinical VT ablation. This article present data from the Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long-term Success Rate of VT Ablation trial [VISTA; NCT01045668].
- Cardiology Clinical Trials
- Interventional Techniques & Devices
- Inflammatory Disease
- Cardiology Clinical Trials
- Cardiology & Cardiovascular Medicine
- Interventional Techniques & Devices
- Inflammatory Disease
- © 2014 MD Conference Express®
Tools
Substrate-Based Ablation Reduces Recurrent Arrhythmia Compared to Focused Ablation in Ischemic Cardiomyopathy with Stable VT
Permalink:
Table of contents
Cited By...
- No citing articles found.